Trial Profile
Continuous subcutaneous infusion of pramlintide and insulin: a randomized, crossover design study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Pramlintide (Primary) ; Insulin
- Indications Type 1 diabetes mellitus
- Focus Pharmacodynamics
- 17 Jul 2008 Actual completion date (November 2007) added as reported by ClinicalTrials.gov.
- 17 Jul 2008 Actual patient number added (13) as reported by ClinicalTrials.gov.
- 17 Jul 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.